Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C☆
To access this article, please choose from the options below
☆ This study was a cooperative agreement funded by the NIDDK and co-funded by the National Center on Minority Health and Health Disparities (NCMHD), with a Cooperative Research and Development Agreement (CRADA) with Roche Laboratories, Inc. Grant Nos. U01 DK60329, U01 DK60340, U01 DK60324, U01 DK60344, U01 DK60327, U01 DK60335, U01 DK60352, U01 DK60342, U01 DK60345, U01 DK60309, U01 DK60346, U01 DK60349, and U01 DK60341. Other support: National Center for Research Resources (NCRR), Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, General Clinical Research Centers Program Grants: M01 RR00645 (New York Presbyterian), M02 RR000079 (University of California, San Francisco), M01 RR16500 (University of Maryland), M01 RR000042 (University of Michigan), and M01 RR00046 (University of North Carolina). Additional support was provided to L.J.Y. by 1KL2 RR024154-01. NIH funded study.
PII: S0168-8278(08)00292-4
doi:10.1016/j.jhep.2008.04.011
© 2008 European Association for the Study of the Liver. All rights reserved.
